Silexion Therapeutics Ltd. (SLXN)
SLXN Stock Price Chart
Explore Silexion Therapeutics Ltd. interactive price chart. Choose custom timeframes to analyze SLXN price movements and trends.
SLXN Company Profile
Discover essential business fundamentals and corporate details for Silexion Therapeutics Ltd. (SLXN) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
16 Aug 2024
Employees
11.00
Website
https://silexion.comCEO
Ilan Hadar
Description
Silexion Therapeutics LTD is a biopharmaceutical company specializing in the discovery and advancement of RNA interference (RNAi)-based cancer therapies and their associated delivery systems, with a focus on treating aggressive solid tumors. The company's strategy for addressing these tumors relies on its proprietary LODER delivery platform. Its product pipeline features several key candidates: SiG12D-LODER, which has progressed through both preclinical studies and an open-label Phase I clinical trial for pancreatic cancer; Prostate-LODER, currently undergoing preclinical evaluation for prostate cancer; and GBM-LODER, also in preclinical development, targeting Glioblastoma Multiforme, a highly malignant primary brain tumor. Founded in 2008, Silexion Therapeutics is headquartered in Jerusalem, Israel.
SLXN Financial Timeline
Browse a chronological timeline of Silexion Therapeutics Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 11 Aug 2026
EPS estimate is -$21.20.
Stock split effective on 29 May 2026
Shares were split 1 : 10 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 15 May 2026
EPS came in at -$8.50 surpassing the estimated -$12.90 by +34.11%.
Earnings released on 17 Mar 2026
EPS came in at -$23.85 falling short of the estimated -$1.17 by -1.94k%.
Earnings released on 12 Nov 2025
EPS came in at -$2.88 surpassing the estimated -$3.40 by +15.29%.
Earnings released on 12 Aug 2025
EPS came in at -$4.32 falling short of the estimated -$3.15 by -37.14%.
Stock split effective on 29 Jul 2025
Shares were split 1 : 15 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 13 May 2025
EPS came in at -$0.26 surpassing the estimated -$3.30 by +92.12%.
Earnings released on 18 Mar 2025
EPS came in at -$11.55 surpassing the estimated -$14.70 by +21.43%.
Stock split effective on 29 Nov 2024
Shares were split 1 : 9 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 14 Nov 2024
EPS came in at -$273.94 falling short of the estimated -$110.70 by -147.46%.
Earnings released on 13 Aug 2024
EPS came in at -$14.85 .
Earnings released on 15 May 2024
EPS came in at -$1.78 .
SLXN Stock Performance
Access detailed SLXN performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
